A physiologically-based pharmacokinetic model of drug detoxification by nanoparticles

被引:13
作者
Fallon, MS
Varshney, M
Dennis, DM
Chauhan, A [1 ]
机构
[1] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA
[2] Univ Florida, Engn Res Ctr Particle Sci & Technol, Gainesville, FL 32611 USA
[3] Univ Florida, Dept Anesthesiol, Gainesville, FL 32611 USA
关键词
absorption; adsorption; drug detoxification; drug overdose; microemulsion; nanoparticle; pharmacokinetic model;
D O I
10.1007/s10928-004-8322-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoparticles (NPs) may be capable of reversing the toxic effects of drug overdoses in humans by adsorbing/absorbing drug molecules. This paper develops a model to include the kinetic effects of treating drug overdoses by NPs. Depending on the size and the nature of the NPs, they may either pass through the capillary walls and enter the tissue space or remain only inside the capillaries and other blood vessels; models are developed for each case. Furthermore, the time scale for equilibration between the NP and the blood will vary with the specific type of NP. The NPs may sequester drug from within the capillaries depending on whether this time scale is larger or smaller than the residence time of blood within the capillary. Models are developed for each scenario. The results suggest that NPs are more effective at detoxification if they are confined to the blood vessels and do not enter the tissues. The results also show that the detoxification process is faster if drug uptake occurs within the capillaries. The trends shown by the model predictions can serve as useful guides in the design of the optimal NP for detoxification.
引用
收藏
页码:381 / 400
页数:20
相关论文
共 16 条
[1]   Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment [J].
Clewell, HJ ;
Gentry, PR ;
Covington, TR ;
Gearhart, JM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :283-305
[2]   Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo [J].
Cole, CE ;
Tran, HT ;
Schlosser, PM .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 2001, 62 (06) :439-465
[3]   FROM PIECEWISE TO FULL PHYSIOLOGICAL PHARMACOKINETIC MODELING - APPLIED TO THIOPENTAL DISPOSITION IN THE RAT [J].
EBLING, WF ;
WADA, DR ;
STANSKI, DR .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (04) :259-292
[4]   Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites [J].
Fisher, JW .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :265-273
[5]  
FOURNIER RL, 1999, BASIC TRANSPORT PHEN
[6]  
Gibaldi M, 1982, Pharmacokinetics, V15
[7]  
Guyton A C., TXB MED PHYSL
[8]  
LUTZ RJ, 1977, J PHARMACOL EXP THER, V200, P469
[9]   Treatment of local anesthetic-induced cardiotoxicity using drug scavenging nanoparticles [J].
Morey, TE ;
Varshney, M ;
Flint, JA ;
Rajasekaran, S ;
Shah, DO ;
Dennis, DM .
NANO LETTERS, 2004, 4 (04) :757-759
[10]  
Poulin P, 2000, J PHARM SCI-US, V89, P16, DOI 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO